| Citation: |
WANG Chunli, ZHENG Bixia, ZHOU Wei, CHE Ruochen, ZHAO Fei, ZHANG Aihua, DING Guixia. Research Analysis of SLC12A3 Gene Mutation and Molecular Mechanism in Gitelman Syndrome[J]. Journal of Rare Diseases, 2024, 3(1): 50-56. DOI: 10.12376/j.issn.2097-0501.2024.01.007
|
This study aimed at conducting retrospective analysis of the clinical symptoms and genetic mutations in 20 children with Gitelman syndrome treated at the Affiliated Children′s Hospital of Nanjing Medical University from August 2015 to November 2022 and also explored the molecular mechanism of the pathogenic high-frequency mutation D486N in the Chinese population.
We collected the clinical manifestations, growth and development status, laboratory examination results, and SLC12A3 gene variations of the patients. We distinguished the wild-type and mutant SLC12A3 genes overexpressed in human embryonic kidney 293T cells (HEK293T). We used protein immunoblotting to detect the expression level of NCC, and used immunofluorescence techniques to examine the subcellular localization of NCC. In addition, we investigated the impact of the high-frequency SLC12A3 gene mutation D486N on NCC protein expression and localization.
In the 20 patients with Gitelman syndrome, all of them had hypokalemia. We indemnified twenty-six SLC12A3 gene mutations, 13 of which are missense mutation, 1 of which synonymous mutation, 1 nonsense mutation, 4 frameshift mutation, and 7 splicing site mutation. Among them, four mutations (p.T235K, c.1096-1G > A, p.A464A, and c.2660+1_2660+2insT) were novel mutations.
We found the preliminary evidence that the high-frequency mutation D486N in the Chinese population affected the expression of total and membrane-bound NCC protein and influenced the membrane localization of NCC protein. The findings of this study provides experimental evidence for genetic counseling, diagnosis, and treatment of Gitelman syndrome.
| [1] |
Blanchard A, Bockenhauer D, Bolignano D, et al. Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes(KDIGO) Controversies Conference[J]. Kidney Int, 2017, 91(1): 24-33. doi: 10.1016/j.kint.2016.09.046
|
| [2] |
Gitelman HJ, Graham JB, Welt LG, et al. A new familial disorder characterized by hypokalemia and hypomagnesemia[J]. Trans Assoc Am Physicians, 1966, 79: 221-235.
|
| [3] |
Tago N, Kokubo Y, Inamoto N, et al. A high prevalence of Gitelman′s syndrome mutations in Japanese[J]. Hypertens Res, 2004, 27(5): 327-331. doi: 10.1291/hypres.27.327
|
| [4] |
Riveira-Munoz E, Chang Q, Bindels RJ, et al. Gitelman′s syndrome: towards genotype-phenotype correlations?[J]. Pediatr Nephrol, 2007, 22(3): 326-332. doi: 10.1007/s00467-006-0321-1
|
| [5] |
Chen HJ, Ma R, Du HZ, et al. Early onset children′s gitelman syndrome with severe hypokalaemia: a case report[J]. BMC Pediat, 2020, 20(1): 366. doi: 10.1186/s12887-020-02265-9
|
| [6] |
Fujimura J, Nozu K, Yamamura T, et al. Clinical and genetic characteristics in patients with Gitelman syndrome[J]. Kidney Int Rep, 2019, 4(1): 119-125. doi: 10.1016/j.ekir.2018.09.015
|
| [7] |
赵喆, 唐彦, 周婧雅, 等. 50例Gitelman综合征患者临床特征和药物治疗分析[J]. 协和医学杂志, 2022, 13(2): 277-286.
|
| [8] |
邵乐平, 逯静茹, 郎艳华, 等. 中国Gitelman综合征患者的基因型、表型分析及随访研究[J]. 中华内分泌代谢杂志, 2017, 33(1): 40-46.
|
| [9] |
Shen Q, Chen J, Yu M, et al. Multi-centre study of the clinical features and gene variant spectrum of Gitelman syndrome in Chinese children[J]. Clin Genet, 2021, 99(4): 558-564. doi: 10.1111/cge.13913
|
| [10] |
李晓侨, 李文京, 刘敏, 等. 儿童Gitelman综合征的临床表现和基因变异分析[J]. 医学研究杂志, 2023, 52(3): 127-132.
|
| [11] |
Glaudemans B, Yntema H, San-Cristobal P, et al. Novel NCC mutants and functional analysis in a new cohort of patients with Gitelman syndrome[J]. Eur J Hum Genet, 2012, 20(3): 263-270. doi: 10.1038/ejhg.2011.189
|
| [12] |
Fujimura J, Nozu K, Yamamura T, et al. Clinical and genetic characteristics in patients with Gitelman syndrome[J]. Kidney Int Rep, 2018, 28, 4(1): 119-125.
|
| [13] |
Wang C, Zhou W, Huang Y, et al. Presumed missense and synonymous mutations in ATP7B gene cause exon skipping in Wilson disease[J]. Liver Int, 2018, 38(8): 1504-1513. doi: 10.1111/liv.13754
|
| [14] |
Jobbins M, Reichenbach F, Lucas M, et al. The mechanisms of a mammalian splicing enhancer[J]. Nucleic Acids Res, 2018, 46(5): 2145-2158. doi: 10.1093/nar/gky056
|
| [15] |
Takeuchi Y, Mishima E, Shima H, et al. Exonic mutations in the SLC12A3 gene cause exon skipping and premature termination in Gitelman syndrome[J]. J Am Soc Nephrol, 2015, 26(2): 271-279. doi: 10.1681/ASN.2013091013
|
| [16] |
Shi X, Wang H, Zhang R, et al. Minigene splicing assays reveal new insights into exonic variants of the SLC12A3 gene in Gitelman syndrome[J]. Mol Genet Genomic Med, 2023, 11(4): e2128. doi: 10.1002/mgg3.2128
|
| [17] |
Lin H, Shiang C, Huang C, et al. Phenotype and genotype analysis in Chinese patients with Gitelman′s syndrome[J]. J Clin Endocrinol Metab, 2005, 90(5): 2500-2507. doi: 10.1210/jc.2004-1905
|
| [18] |
Mou L, Tang M, Zhu L, et al. Spectrum of variants in a large Chinese Gitelman syndrome cohort[J]. Clin Genet, 2023, 104(6): 674-678. doi: 10.1111/cge.14422
|
| [19] |
De Jong JC, Van Der Vliet WA, Van Den Heuvel LP, et al. Functional expression of mutations in the human NaCl cotransporter: evidence for impaired routing mechanisms in Gitelman′s syndrome[J]. J Am Soc Nephrol, 2002, 13(6): 1442-1448. doi: 10.1097/01.ASN.0000017904.77985.03
|
| [20] |
Wang F, Shi C, Cui Y, et al. Mutation profile and treatment of Gitelman syndrome in Chinese patients[J]. Clin Exp Nephrol, 2017, 21(2): 293-299. doi: 10.1007/s10157-016-1284-6
|
| [21] |
Yang S, Fang W, Tseng H, et al. Phosphorylation regulates NCC stability and transporter activity in vivo[J]. J Am Soc Nephrol, 2013, 24(10): 1587-1597. doi: 10.1681/ASN.2012070742
|
| [1] | ZHU Ke, SUN Bijun, WANG Wenjie, ZHOU Qinhua, LIU Luyao, HOU Jia, WANG Xiaochuan, SUN Jinqiao. Clinical Characteristics of Three Cases with SAMD9/SAMD9L Gene Mutations[J]. Journal of Rare Diseases, 2024, 3(4): 507-511. DOI: 10.12376/j.issn.2097-0501.2024.04.014 |
| [2] | ZHAO Min, SHU Zhou, HAN Tongxin, FU Yanhua, GAO Tianji, MAO Huawei. A Case Report of Aicardi-Goutières Syndrome Type 7 Caused by IFIH1 Gene Mutation and a Literature Review[J]. Journal of Rare Diseases, 2024, 3(4): 453-460. DOI: 10.12376/j.issn.2097-0501.2024.04.007 |
| [3] | QI Zhan, GUO Ruolan, HU Xuyun, GUO Jun, HAO Chanjuan. Two Cases of Autosomal Recessive Marinesco-Sjögren Syndrome Caused by SIL1 Gene Mutations[J]. Journal of Rare Diseases, 2024, 3(3): 358-362. DOI: 10.12376/j.issn.2097-0501.2024.03.013 |
| [4] | LIN Wanjun, LIANG Cuili, FU Wen, ZHANG Liyu, JIA Wei, HU Jinhua, ZHANG Wen, LIN Yunting, NIU Huilin, FAN Liping, LU Zhikun, LI Duan, LIU Zongcai, SHENG Huiying, YIN Xi, CHEN Xiaodan, LIU Guochang, CHENG Jing, LIU Li. Clinical Manifestations, Molecular Genetics and Gonadal Pathology of 416 Patients with Disorders of Sex Development: A Single-Center Cohort Study[J]. Journal of Rare Diseases, 2024, 3(3): 310-317. DOI: 10.12376/j.issn.2097-0501.2024.03.006 |
| [5] | ZHANG Luyan, ZHENG Bixia, ZHANG Aihua. Research Progress of Monogenic Mutation in the Pathogenesis of Steroid-Resistant Nephrotic Syndrome[J]. Journal of Rare Diseases, 2024, 3(1): 18-29. DOI: 10.12376/j.issn.2097-0501.2024.01.003 |
| [6] | CHEN Meiping, YANG Hongbo, PAN Hui, FENG Feng, ZHU Yicheng, ZHU Huijuan. Clinical Features and Mutation Analysis of Gordon Holmes Syndrome Associated with RNF216 Gene Mutation and a Literature Review[J]. Journal of Rare Diseases, 2023, 2(3): 337-345. DOI: 10.12376/j.issn.2097-0501.2023.03.004 |
| [7] | LIU Zhouliang, YANG Chao, WANG Huijun, LIN Zhimiao. Clinical Features and Mutation Analysis of the SMARCAD1 Gene in a Family with Basan Syndrome and a Literature Review[J]. Journal of Rare Diseases, 2023, 2(2): 178-185. DOI: 10.12376/j.issn.2097-0501.2023.02.006 |
| [8] | ZHENG Yi, JIA Tao, YAN Cong, ZHANG Xinyue, DU Xueshan, ZHOU Tong, SONG Xiangjin, GENG Songmei. Analysis of 8 Cases of Blau Syndrome/Early-onset Sarcoidosis——Clinical Manifestations, Histopathology Features and Gene Mutation Diversity[J]. Journal of Rare Diseases, 2023, 2(2): 170-177. DOI: 10.12376/j.issn.2097-0501.2023.02.005 |
| [9] | ZHAO Chenzi, ZHANG Qing, LI Zhigang. Progress in Biological Functions of NBAS Gene and Related Diseases[J]. Journal of Rare Diseases, 2022, 1(3): 359-364. DOI: 10.12376/j.issn.2097-0501.2022.03.021 |
| [10] | Rare Diseases Society of Chinese Research Hospital Association, China Alliance for Rare Disease, Beijing Society of Rare Disease Clinical Care and Accessibility, Gitelman Syndrome Consensus Working Group. Expert Consensus for the Diagnosis and Treatment of Gitelman Syndrome in China (2021)[J]. Journal of Rare Diseases, 2022, 1(1): 56-67. DOI: 10.12376/j.issn.2097-0501.2022.01.010 |
Official account
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Author
Peer Review
Editorial Entry
Editor Work
DownLoad: